Balancing protective immunity and immunopathology

被引:45
作者
Bachmann, MF
Kopf, M
机构
[1] Cytos Biotechnol AG, CH-8952 Schlieren, Switzerland
[2] Swiss Fed Inst Technol, Dept Environm Sci, CH-8952 Schlieren, Switzerland
关键词
D O I
10.1016/S0952-7915(02)00363-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system is fighting a constant war against pathogens in its own territory. This requires a potent arsenal for efficient control of pathogens but also requires tight regulatory mechanisms in order to avoid excessive collateral damage. Maintaining equilibrium is the daily challenge of the immune system. Interactions between pathogens, antigen-presenting cells (APCs) and lymphocytes are critical in this balancing act, Of particular importance for the generation of protective immune responses is the induction of activation programs in APCs directly by pathogens or by T cell derived factors, such as CD40L, RANKL or cytokines, In order to counterbalance overshooting immune responses, T cells and APCs secrete anti-inflammatory cytokines that are key for maintaining a healthy balance between protection and immunopathology.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 96 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
    Alexopoulou, L
    Holt, AC
    Medzhitov, R
    Flavell, RA
    [J]. NATURE, 2001, 413 (6857) : 732 - 738
  • [3] Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
    Aliprantis, AO
    Yang, RB
    Mark, MR
    Suggett, S
    Devaux, B
    Radolf, JD
    Klimpel, GR
    Godowski, P
    Zychlinsky, A
    [J]. SCIENCE, 1999, 285 (5428) : 736 - 739
  • [4] Interleukin 6 is required for the development of collagen-induced arthritis
    Alonzi, T
    Fattori, E
    Lazzaro, D
    Costa, P
    Probert, L
    Kollias, G
    De Benedetti, F
    Poli, V
    Ciliberto, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) : 461 - 468
  • [5] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [6] Bachmann MF, 1999, J IMMUNOL, V163, P1128
  • [7] Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.0.CO
  • [8] 2-X
  • [9] Neutralizing antiviral B cell responses
    Bachmann, MF
    Zinkernagel, RM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 235 - 270
  • [10] TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
    Bachmann, MF
    Wong, BR
    Josien, R
    Steinman, RM
    Oxenius, A
    Choi, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) : 1025 - 1031